| Literature DB >> 29473483 |
Elizabeth Sherman1,2, Kevin Alan Clauson3, Shara Elrod4, Paula Eckardt2, Fadi Alkhateeb5, Robin Jacobs6.
Abstract
Evidence on the use of short message service (SMS) to improve medication adherence in people living with HIV (PLHIV) is mounting, yet qualitative research on patient perceptions regarding SMS content and utility for HIV/AIDS remains nascent. To explore the experience of receiving medication reminders via SMS among PLHIV, 45 uninsured and underinsured PLHIV nested within the intervention arm of a larger study received daily, 1-way SMS adherence reminders. Qualitative data were collected by face-to-face, structured interview and were analyzed using conventional content analysis methods. Three main themes emerged from the data: (1) reminders helping with adherence, (2) concerns about delivery modes, and (3) the need for confidentiality. Study findings offer enhanced focus on an emerging strategy in patient-centered HIV care: Equipped with greater context on the experiences of PLHIV using SMS adherence reminders, health-care providers can offer more targeted support and thereby maximize the benefits of this popular and powerful technology.Entities:
Keywords: HIV; SMS; mobile health; qualitative; text message
Mesh:
Substances:
Year: 2018 PMID: 29473483 PMCID: PMC6748548 DOI: 10.1177/2325958218759209
Source DB: PubMed Journal: J Int Assoc Provid AIDS Care ISSN: 2325-9574
Study Participants’ Baseline Characteristics.a
| Variable | Mean (Standard Deviation) or Frequency Count (%) |
|---|---|
| Age, years | 37.5 (11.6) |
| Gender | |
| Male | 28 (62%) |
| Female | 17 (38%) |
| Race/ethnicity | |
| Black/African American | 32 (71%) |
| Hispanic/Latino | 9 (20%) |
| White, non-Hispanic | 4 (9%) |
| HIV risk factor at screening | |
| Heterosexual sex | 29 (64%) |
| Men having sex with men (MSM) | 12 (27%) |
| MSM and heterosexual sex | 2 (4%) |
| Unknown | 2 (4%) |
| Average number of text messages sent and received each day | |
| 0-9 | 22 (49%) |
| 10-49 | 13 (29%) |
| 50-99 | 4 (9%) |
| 100+ | 6 (13%) |
| Antiretroviral regimen prescribed | |
| Nonnucleoside reverse transcriptase inhibitor | 24 (53%) |
| Protease inhibitor | 11 (25%) |
| Integrase strand transfer inhibitor | 10 (22%) |
| HIV RNA log10 | |
| 2.00-3.99 | 12 (27%) |
| 4.00-4.99 | 14 (31%) |
| 5.00-5.99 | 15 (33%) |
| 6.00+ | 4 (9%) |
aN = 45.